Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

Published:2013-05-30 Issue:11 Volume:108 Page:2259-2263
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Zagouri F,Sergentanis T N,Koutoulidis V,Sparber C,Steger G G,Dubsky P,Zografos G C,Psaltopoulou T,Gnant M,Dimopoulos M-A,Bartsch R

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2013255.pdf

Reference31 articles.

1. Aebi S, Davidson T, Gruber G, Cardoso F ESMO Guidelines Working Group (2011) Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 22: vi12–vi24.

2. Arriola E, Hui E, Dowsett M, Smith IE (2007) Aromatase inhibitors and male breast cancer. Clin Transl Oncol 9: 192–194.

3. Bighin C, Lunardi G, Del Mastro L, Marroni P, Taveggia P, Levaggi A, Giraudi S, Pronzato P (2010) Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitors. Oncologist 15: 1270–1272.

4. Bliss JM, Kilburn LS, Coleman RE, Forbes JF, Coates AS, Jones SE, Jassem J, Delozier T, Andersen J, Paridaens R, van de Velde CJ, Lønning PE, Morden J, Reise J, Cisar L, Menschik T, Coombes RC (2012) Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study. J Clin Oncol 30: 709–717.

5. Bonneterre J, Thürlimann B, Robertson JF, Krzakowski M, Mauriac L, Koralewski P, Vergote I, Webster A, Steinberg M, von Euler M . Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability study (2000) J Clin Oncol 18: 3748–3757.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond;Cancers;2024-01-30

2. Breast cancer cells are sensitized by piperine to radiotherapy through estrogen receptor-α mediated modulation of a key NHEJ repair protein- DNA-PK;Phytomedicine;2024-01

3. Male Breast Cancer (MBC) – A Review;Polish Journal of Surgery;2023-12-30

4. The incidence of male breast cancer: from fiction to reality – correspondence;International Journal of Surgery;2023-05-23

5. Male Breast Cancer: From Molecular Genetics to Clinical Management;Cancers;2022-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3